ACTIVITY DETAILS

A Case of Connecting the Dots: Improving Diagnosis and Management of Fibromyalgia

neuroscienceCME Chart Review
Premiere Date: Wednesday, May 19, 2010
This activity offers CE credit for:

Physicians (ACCME/AMA PRA Category 1)
Nurses (CNE)
Pharmacists (ACPE)
All other clinicians will either receive a CME Attendance Certificate or may choose any of the types of CE credit being offered.
Credit Expiration Date:
Thursday, May 19, 2011

Faculty

Lesley M. Arnold, MD
Professor of Psychiatry
Director, Women’s Health Research Program
University of Cincinnati College of Medicine
Cincinnati, OH

Don L. Goldenberg, MD
Chief of Rheumatology
Newton-Wellesley Hospital
Newton, MA
Professor of Medicine
Tufts University School of Medicine
Boston, MA

Matthew J. Bair, MD (Content/Peer Reviewer)
Assistant Professor of Medicine
Indiana University School of Medicine
Bloomington, IN

Statement of Need

Pain is a common complaint in the primary care setting, and the standard of practice is to assess for the cause of the pain. Patients often present with painful symptoms of unknown etiology that cannot be defined by the degree of inflammation or damage to muscle tissue. Fibromyalgia affects an estimated 10 million people in the United States and is especially common in women. Many patients have additional symptoms including fatigue, headaches, irritable bowel syndrome, cognitive problems/memory lapses, sleep disturbances, anxiety, and depression. A recent CME Outfitters survey found that 62.8% of respondents were not confident or only somewhat confident in their ability to diagnose and manage fibromyalgia. In this neuroscienceCME Clinical Chart Review, the faculty will take participants through a patient case to demonstrate the complexities of appropriate assessment, diagnosis, and management of fibromyalgia, and provide insights and strategies for improving patient care and long-term outcomes.

Russell IJ, Raphael KG. Fibromyalgia syndrome: presentation, diagnosis, differential diagnosis, and vulnerability. CNS Spectr 2008;13:6-11.

Activity Goal

To improve the assessment, diagnosis, and treatment of patients with fibromyalgia.

Learning Objectives

At the end of this CE activity, participants should be able to:

Identify assessment and diagnostic indicators that differentiate fibromyalgia from other pain disorders.
Define the role of multimodal and multidisciplinary approaches to the management of fibromyalgia.

Target Audience

Physicians, physician assistants, nurse practitioners, nurses, pharmacists, and other healthcare professionals interested in fibromyalgia.

Financial Support

Indiana University School of Medicine and CME Outfitters, LLC, gratefully acknowledge an educational grant from Pfizer Inc. in support of this CE activity.

This CME/CE-certified activity is funded in part by CME Outfitters, LLC.

Credit Information

CME Credit (Physicians):

Accreditation Statement:
Indiana University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement:
Indiana University School of Medicine designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Note to Physician Assistants: AAPA accepts Category I credit from AOACCME, Prescribed credit from AAFP, and AMA Category I CME credit for the PRA from organizations accredited by ACCME.

CNE Credit (Nurses):
(Live activity) This continuing nursing education activity was approved by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

It has been assigned approval code 84QRBW-10. 1.0 contact hours will be awarded upon successful completion.

(Archive activity) This continuing nursing education activity was approved by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

It has been assigned approval code 84QRGW-10. 1.0 contact hours will be awarded upon successful completion.

CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.0 contact hours (0.1 CEUs)
Universal Program Number:
376-999-10-012-L01-P (live presentation)
376-999-10-012-H01-P (recorded programs)
Activity Type: knowledge-based

Post-tests, credit request forms, and activity evaluations must be completed online at www.neuroscienceCME.com (click on the Testing/Certification link under the Activities tab - requires free account activation), and participants can print their certificate or statement of credit immediately (80% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit www.neurosciencecme.com/technical.asp.

This continuing education activity is co-sponsored by Indiana University School of Medicine and by CME Outfitters, LLC.

Disclosure Declaration

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Indiana University School of Medicine (IUSM) and CME Outfitters, LLC, (CMEO) must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, and planning committee members participating in activities sponsored by IUSM and CMEO are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
Note: While it offers CME credits, this activity is not intended to provide extensive training or certification in the field.

Dr. Arnold has disclosed that she receives grants/research support from Allergan, Inc., Boehringer Ingelheim Pharamceuticals, Inc., Cypress Bioscience, Inc., Eli Lilly and Company, Forest Laboratories, Inc., Pfizer Inc., and Wyeth Pharmaceuticals. She serves as a consultant to Allergan, Inc., AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharamceuticals, Inc., Cypress Bioscience, Inc., Eli Lilly and Company, Forest Laboratories, Inc., Pfizer Inc., Sanofi-aventis, Takeda Pharmaceuticals North America, Inc., Theravance, Inc., UCB Pharma, and Wyeth Pharmaceuticals.

Dr. Goldenberg has disclosed that he serves as a consultant to Eli Lilly and Company, Forest Laboratories, Inc., and Pfizer Inc.

Dr. Bair has no disclosures.

Unlabeled Use Disclosure

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Indiana University School of Medicine, CME Outfitters, LLC, the faculty, and Pfizer Inc. do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.

Questions about this activity? Call us at 877.CME.PROS (877.263.7767).

CR-004-051910-02